APA

Tsai D. E., Hardy C. L., Tomaszewski J. E., Kotloff R. M., Oltoff K. M., Somer B. G., Schuster S. J., Porter D. L., Montone K. T. & Stadtmauer E. A. (20010621). Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. : Transplantation.

Chicago

Tsai D E, Hardy C L, Tomaszewski J E, Kotloff R M, Oltoff K M, Somer B G, Schuster S J, Porter D L, Montone K T and Stadtmauer E A. 20010621. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. : Transplantation.

Harvard

Tsai D. E., Hardy C. L., Tomaszewski J. E., Kotloff R. M., Oltoff K. M., Somer B. G., Schuster S. J., Porter D. L., Montone K. T. and Stadtmauer E. A. (20010621). Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. : Transplantation.

MLA

Tsai D E, Hardy C L, Tomaszewski J E, Kotloff R M, Oltoff K M, Somer B G, Schuster S J, Porter D L, Montone K T and Stadtmauer E A. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. : Transplantation. 20010621.